Kortikosteroid sebagai terapi adjuvan untuk toksoplasmosis okular
Information
- DOI:
- https://doi.org/10.1002/14651858.CD007417.pub3Copy DOI
- Database:
-
- Cochrane Database of Systematic Reviews
- Version published:
-
- 26 January 2017see what's new
- Type:
-
- Intervention
- Stage:
-
- Review
- Cochrane Editorial Group:
-
Cochrane Eyes and Vision Group
- Copyright:
-
- Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Article metrics
Altmetric:
Cited by:
Authors
Contributions of authors
Conceiving the review: QDN
Designing the review: QDN, SSV, SJ
Co‐ordinating the review: SSV, SJ
Data collection for the review
-
Designing electronic search strategies: Cochrane Eyes and Vision Group editorial base
-
Undertaking manual searches: QDN, SSV
-
Screening search results: SJ, QDN, SSV, YJS
-
Organizing retrieval of papers: SSV
-
Screening retrieved papers against inclusion criteria: SJ, SSV, YJS
-
Appraising quality of papers: QDN, SSJ, SSV
-
Extracting data from papers: SJ, SH, QDN, SSV
-
Writing to authors of papers for additional information: QDN, SSV, SJ
-
Providing additional data about papers: SSV, SJ, SH, SSJ
-
Obtaining and screening data on unpublished studies: QDN, SSV, SJ
Data management for the review
-
Entering data into RevMan: SSV, SJ
-
Analysis of data: SSV, QDN, SJ
Interpretation of data
-
Providing a methodological perspective: SSV
-
Providing a clinical perspective: QDN, SJ, SH, SSJ, YJS
-
Providing a policy perspective: QDN, SJ
-
Providing a consumer perspective: QDN, SJ
-
Writing the review: QDN, SSV, SJ, SH, SSJ, YJS
-
Providing general advice on the review: QDN, SSV, SH, SSJ, YJS
Securing funding for the review: not applicable
Performing previous work that was the foundation of the current study: QDN, SJ, SSJ, SH
Updating the review: QDN, SSV, SJ, SH, SSJ, YJS
Sources of support
Internal sources
-
Johns Hopkins University, USA.
External sources
-
Contract N01‐EY‐2‐1003, National Eye Institute, National Institutes of Health for the Cochrane Eyes and Vision Group US Project, USA.
-
Grant 1 U01 EY020522, National Eye Institute, National Institutes of Health for the Cochrane Eyes and Vision US Project, USA.
-
National Institute for Health Research (NIHR), UK.
-
Richard Wormald, Co‐ordinating Editor for Cochrane Eyes and Vision (CEV) acknowledges financial support for his CEV research sessions from the Department of Health through the award made by the NIHR to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology.
-
The NIHR also funds the CEV editorial base in London.
The views expressed in this publication are those of the review authors and not necessarily those of the NIHR, the NHS or the Department of Health.
-
Declarations of interest
SJ: none known.
SSV: none known.
SSJ: none known.
SH: none known.
YJS: none known.
QDN: none known.
Acknowledgements
We thank the peer reviewers including Barbara Hawkins and Ruth Gilbert for their comments on the protocol for this review. Iris Gordon, Information Specialist for Cochrane Eyes and Vision (CEV), designed and conducted the electronic searches. The CEV editorial base and CEV US Project provided logistical support and editorial comments for this review and its protocol. Isabel Rodriguez‐Barraquer and Stephan Ehrhardt provided assistance with translating papers published in Spanish and German, respectively, to assess eligibility for inclusion in this systematic review.
Version history
| Published | Title | Stage | Authors | Version |
| 2017 Jan 26 | Corticosteroids as adjuvant therapy for ocular toxoplasmosis | Review | Smitha Jasper, Satyanarayana S Vedula, Sheeja S John, Saban Horo, Yasir J Sepah, Quan Dong Nguyen | |
| 2013 Apr 30 | Corticosteroids as adjuvant therapy for ocular toxoplasmosis | Review | Smitha Jasper, Satyanarayana S Vedula, Sheeja S John, Saban Horo, Yasir J Sepah, Quan Dong Nguyen | |
| 2008 Oct 08 | Corticosteroids for ocular toxoplasmosis | Protocol | Satyanarayana S Vedula, Quan D Nguyen | |
Differences between protocol and review
We specified in the protocol for this review that ocular discomfort was part of the primary outcome (Vedula 2008). In response to peer review, and acknowledging the reviewers' concerns about lack of validated measures for assessing ocular discomfort, we revised the description of the primary outcome for the review by omitting ocular discomfort as of 2013 (Jasper 2013).
For this review update, we outlined methods to assess the certainty of evidence using the GRADE approach and to present a 'Summary of findings' table when data become available, as recommended by Cochrane.
Keywords
MeSH
Medical Subject Headings (MeSH) Keywords
Medical Subject Headings Check Words
Humans;
